U.S. Markets closed

Can The Uptrend Continue for Synthetic Biologics (SYN)?

Zacks Equity Research

Investors certainly have to be happy with Synthetic Biologics Inc SYN and its short term performance. After all, the stock has jumped by 16.9% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for SYN?

While we can never know for sure, it is pretty encouraging that estimates for SYN have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.You can seethe complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Sell These Stocks. Now.

Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500. 

See today's Zacks ""Strong Sells"" absolutely free >>.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Click for Free Synthetic Biologics, Inc (SYN) Stock Analysis Report >>
 
To read this article on Zacks.com click here.
 
Zacks Investment Research